| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |